These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8216455)

  • 1. Concentrations of cefodizime in bronchial secretions after single intravenous administration.
    Pacheco Y; Pirollet B; Taviot B; Coppere B; Perrin-Fayolle M; Dagrosa EE; Damm D
    Arzneimittelforschung; 1993 Aug; 43(8):924-6. PubMed ID: 8216455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Penetration of cefotaxime into bronchial secretions].
    Bergogne-Berezin E; Morel C; Pierre J; Monrocq N; Dournovo P; Benard Y
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):501-5. PubMed ID: 6289226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the diffusion of cefmenoxime into the bronchial secretions.
    Serieys C; Bergogne-Berezin E; Kafe H; Bryskier A
    Chemotherapy; 1986; 32(1):1-6. PubMed ID: 3456295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of cefotaxime into bronchial secretions.
    Bergogne-Berezin E; Morel C; Pierre J; Monrocq N; Dournovo P; Benard Y
    Rev Infect Dis; 1982; 4 Suppl():S392-5. PubMed ID: 6294788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
    Dagrosa EE; Hajdú P; Malerczyk V; de Looze S; Seeger K; Grötsch H
    Clin Ther; 1987; 10(1):18-31. PubMed ID: 3450392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of cefotaxime and desacetylcefotaxime in the blood serum and bronchial secretion in patients with chronic bronchitis after administration of a single 24-hour dose].
    Kamnev IuV; Manuĭlov KK; Orlov VA; Sokolova VI
    Antibiot Khimioter; 1991 Oct; 36(10):42-4. PubMed ID: 1805696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefodizime once daily in the treatment of lower respiratory tract infections.
    Piovano CF; Palombini BC; Dagrosa EE; Mendoza F; Facco EB
    Arzneimittelforschung; 1997 May; 47(5):674-7. PubMed ID: 9205786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brodimoprim concentrations in bronchial mucosa, bronchial secretions and middle ear effusions.
    Scaglione F; Cogo R; Pintucci JP; Demartini G; Dugnani S; Maccarinelli G; Fraschini F
    J Chemother; 1993 Dec; 5(6):490-3. PubMed ID: 8195843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of ofloxacin into bronchial secretions.
    Symonds J; Bone M; Turner A; Javaid A
    Drugs; 1987; 34 Suppl 1():33-6. PubMed ID: 3481325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of cefsulodin into bronchial secretions.
    Bergogne-Berezin E; Berthelot G; Safran D; Even P; Kafe H
    Chemotherapy; 1984; 30(4):205-10. PubMed ID: 6744972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of danofloxacin into the respiratory tract tissues and secretions in calves.
    Friis C
    Am J Vet Res; 1993 Jul; 54(7):1122-7. PubMed ID: 8396371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics and production of granulocyte-macrophage colony-stimulating factor by human bronchial epithelial cells in vitro. A comparison of cefodizime and ceftriaxone.
    Pacheco Y; Hosni R; Dagrosa EE; Gormand F; Guibert B; Chabannes B; Lagarde M; Perrin-Fayolle M
    Arzneimittelforschung; 1994 Apr; 44(4):559-63. PubMed ID: 8011012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of cefotaxime into respiratory secretions.
    Fick RB; Alexander MR; Prince RA; Kasik JE
    Antimicrob Agents Chemother; 1987 May; 31(5):815-7. PubMed ID: 3606080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefodizime in normal individuals and in patients with renal failure.
    el Guinaidy MA; Nawishy S; Abd el Bary M; Sabbour MS
    Chemotherapy; 1991; 37(2):77-85. PubMed ID: 2032473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose pharmacokinetics of cefodizime in critically ill elderly patients.
    Meyer B; Traunmueller F; Bojic A; Locker G; Schmid R; Winkler S; Thalhammer F
    Int J Antimicrob Agents; 2006 Apr; 27(4):335-8. PubMed ID: 16563704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Penetration of mezlocillin into bronchial secretions (author's transl)].
    Morel C; Benard Y; Vergnaud M; Langeard M
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):365-7. PubMed ID: 6460977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic profile of cefodizime.
    Brockmeier D; Dagrosa EE
    Infection; 1992; 20 Suppl 1():S14-7. PubMed ID: 1526669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetration of ampicillin ('Pondocillin') and amoxycillin ('Imacillin') into bronchial secretions.
    Hagstad H
    Pharmatherapeutica; 1984; 3(10):692-7. PubMed ID: 6463069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of cefpodoxime in serum and bronchial mucosal biopsies.
    Baldwin DR; Wise R; Andrews JM; Honeybourne D
    J Antimicrob Chemother; 1992 Jul; 30(1):67-71. PubMed ID: 1429338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefodizime in serum and skin blister fluid after single intravenous and intramuscular doses in healthy volunteers.
    Korting HC; Schäfer-Korting M; Maass L; Klesel N; Mutschler E
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1822-5. PubMed ID: 3435129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.